These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 22582553)

  • 21. Multiparameter flow cytometric analysis reveals low percentage of bone marrow hematogones in myelodysplastic syndromes.
    Maftoun-Banankhah S; Maleki A; Karandikar NJ; Arbini AA; Fuda FS; Wang HY; Chen W
    Am J Clin Pathol; 2008 Feb; 129(2):300-8. PubMed ID: 18208811
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The role of flow cytometric immunophenotyping in myelodysplastic syndromes.
    Pagnucco G; Giambanco C; Gervasi F
    Ann N Y Acad Sci; 2006 Nov; 1089():383-94. PubMed ID: 17261782
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Flow cytometry immunophenotyping for the evaluation of bone marrow dysplasia.
    Della Porta MG; Lanza F; Del Vecchio L;
    Cytometry B Clin Cytom; 2011; 80(4):201-11. PubMed ID: 21674774
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Diagnostic significance of immunophenotyping of bone marrow cells in myelodysplastic syndrome without an increase of marrow blasts].
    Xu J; Zhang W; Liu Y; Wan SG; Sun XJ; Zhao H
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2009 Dec; 17(6):1477-81. PubMed ID: 20030930
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Flow cytometry evaluation of erythroid and myeloid dysplasia in patients with myelodysplastic syndrome.
    Malcovati L; Della Porta MG; Lunghi M; Pascutto C; Vanelli L; Travaglino E; Maffioli M; Bernasconi P; Lazzarino M; Invernizzi R; Cazzola M
    Leukemia; 2005 May; 19(5):776-83. PubMed ID: 15789068
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Transformation of myelodysplastic syndromes into acute myeloid leukemias.
    Shi J; Shao ZH; Liu H; Bai J; Cao YR; He GS; Tu MF; Wang XL; Hao YS; Yang TY; Yang CL
    Chin Med J (Engl); 2004 Jul; 117(7):963-7. PubMed ID: 15265365
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Significance and application value of multiparameter flow cytometry for differentiation of immunophenotype in chronic myelomonocytic leukemia, myelodysplastic syndrome and acute monocytic leukemia].
    Wang YX; Zhang JH; Hu YP; Cao FF; Zhang N; Chen F; Liu X; Zhang MY
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2012 Aug; 20(4):857-62. PubMed ID: 22931642
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Bone marrow cells from myelodysplastic syndromes show altered immunophenotypic profiles that may contribute to the diagnosis and prognostic stratification of the disease: a pilot study on a series of 56 patients.
    Matarraz S; López A; Barrena S; Fernandez C; Jensen E; Flores-Montero J; Rasillo A; Sayagues JM; Sánchez ML; Bárcena P; Hernandez-Rivas JM; Salvador C; Fernandez-Mosteirín N; Giralt M; Perdiguer L; Laranjeira P; Paiva A; Orfao A
    Cytometry B Clin Cytom; 2010 May; 78(3):154-68. PubMed ID: 20198685
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Improved flow cytometric identification of myelopoiesis by the simultaneous labelling with CD13, CD14 and CD66 monoclonal antibodies.
    Bonde J; Meyer K; Broe MK; Hokland M; Turley H; Hokland P
    Br J Haematol; 1996 Feb; 92(2):269-79. PubMed ID: 8602985
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prognostic relevance of cytometric quantitative assessment in patients with myelodysplastic syndromes.
    Falco P; Levis A; Stacchini A; Ciriello MM; Geuna M; Notari P; Omedè P; Pautasso M; Prato G; Strola G; Gioia D; Bonferroni M; Cametti G; Ferrero D; Freilone R; Gaidano G; Marinone C; Marmont F; Pollio B; Salvi F; Saglio G; Girotto M;
    Eur J Haematol; 2011 Nov; 87(5):409-18. PubMed ID: 21711395
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Advanced pediatric myelodysplastic syndromes: can immunophenotypic characterization of blast cells be a diagnostic and prognostic tool?
    Veltroni M; Sainati L; Zecca M; Fenu S; Tridello G; Testi AM; Merlone AD; Buldini B; Leszl A; Lo Nigro L; Longoni D; Bernini G; Basso G;
    Pediatr Blood Cancer; 2009 Mar; 52(3):357-63. PubMed ID: 19061215
    [TBL] [Abstract][Full Text] [Related]  

  • 32. CD71 (transferrin receptor): an effective marker for erythroid precursors in bone marrow biopsy specimens.
    Marsee DK; Pinkus GS; Yu H
    Am J Clin Pathol; 2010 Sep; 134(3):429-35. PubMed ID: 20716799
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Abnormality of immunophenotyping in patients with myelodysplastic syndrome].
    Xu J; Guo YX; Zhao H; Hui WH; Wan SG; Sun XJ
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2009 Aug; 17(4):894-7. PubMed ID: 19698224
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Flow cytometric scoring system as a diagnostic and prognostic tool in myelodysplastic syndromes.
    Chu SC; Wang TF; Li CC; Kao RH; Li DK; Su YC; Wells DA; Loken MR
    Leuk Res; 2011 Jul; 35(7):868-73. PubMed ID: 21397943
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Study on the transformation from myelodysplastic syndromes into acute leukemias].
    Shi J; Shao Z; Liu H; Li K; Song L; Zhang Y; Zheng Y; Chen G; Chu Y; He H; Zhao M; He G; Feng B; Hao Y; Yang T; Yang C
    Zhonghua Xue Ye Xue Za Zhi; 2001 Jul; 22(7):351-4. PubMed ID: 11877096
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A multiparametric flow cytometry immunophenotypic scoring system for the diagnosis and prognosis of myelodysplastic syndromes.
    Huang J; Lai P; Zhou M; Weng J; Lu Z; Du X
    Clin Lab; 2012; 58(11-12):1241-51. PubMed ID: 23289195
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Flow-cytometric analysis of peripheral blood neutrophils: a simple, objective, independent and potentially clinically useful assay to facilitate the diagnosis of myelodysplastic syndromes.
    Cherian S; Moore J; Bantly A; Vergilio JA; Klein P; Luger S; Bagg A
    Am J Hematol; 2005 Jul; 79(3):243-5. PubMed ID: 15981222
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Use of a Blast Dominance-Hematogone Index for the Flow Cytometric Evaluation of Myelodysplastic Syndrome (MDS).
    Schenkel JM; Hergott CB; Dudley G; Drew M; Charest K; Dorfman DM
    Am J Clin Pathol; 2019 May; 151(6):584-592. PubMed ID: 30854558
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Immunophenotypic characterization of myelopoiesis in early and late myelodysplastic syndromes: use of CD44 as an aid in early diagnosis.
    Karmon Y; Manaster J; Chezar J
    Cytometry; 2002 Aug; 50(4):225-30. PubMed ID: 12210602
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Study on the immunophenotype of myeloid cells in myelodysplastic syndromes and its clinical implications].
    Shao Z; Chen G; Lin Z; Zhang Y; Hao Y; Chu Y; Qian L; Yang T; Yang C; Feng B
    Zhonghua Xue Ye Xue Za Zhi; 1997 Feb; 18(2):80-3. PubMed ID: 15622783
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.